HR Execs on the Move

SteadyMed

www.steadymed.com

 
SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.steadymed.com
  • 2603 Camino Ramon Suite 350
    San Ramon, CA USA 94583
  • Phone: 925.272.4999

Executives

Name Title Contact Details

Similar Companies

Temps Bed

Temps Bed is a Elkhart, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelerate Diagnostics

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

Diopsys Inc

Diopsys Inc is a Pine Brook, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bone Biologics

Bone Biologics was founded by University of California Los Angeles professors in collaboration with an Osaka University professor, and a USC surgeon in 2004. Formed to pursue regenerative medicine for bone, the company currently has as its strategic partners the Musculoskeletal Transplant Foundation, the nation's leading tissue bank and Orthofix, a leading global medical device company. Bone Biologics is currently focused on bone regeneration in spinal fusion using its recombinant human protein known as Nell-1. Nell-1 is an osteoinductive orthobiologic; a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.

Medi-Globe Corporation

Medi-Globe Corporation is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.